Perspective Therapeutics (CATX) Liabilities from Discontinued Operations (2022 - 2024)

Perspective Therapeutics' Liabilities from Discontinued Operations history runs 3 years deep, the most recent figure standing at 5070000.0 for Q1 2024.

• In Q1 2024, Liabilities from Discontinued Operations changed N/A year-over-year to 5070000.0; the TTM figure through Mar 2024 stood at 5070000.0 (changed N/A YoY), while the FY2023 annual figure was 5072000.0, up 1432.33% from the prior year.
• Liabilities from Discontinued Operations came in at 5070000.0 for Q1 2024 at Perspective Therapeutics, roughly flat from 5072000.0 in the prior quarter.
• In the past five years, Liabilities from Discontinued Operations ranged from a high of 5072000.0 in Q4 2023 to a low of 331000.0 in Q4 2022.
• A 3-year average of 3491000.0 and a median of 5070000.0 in 2024 frame the typical range for Liabilities from Discontinued Operations.
• On a YoY basis, Liabilities from Discontinued Operations climbed as much as 1432.33% in 2023 and fell as far as 1432.33% in 2023.
• Perspective Therapeutics' Liabilities from Discontinued Operations stood at 331000.0 in 2022, then surged by 1432.33% to 5072000.0 in 2023, then declined by 0.04% to 5070000.0 in 2024.
• According to Business Quant data, Liabilities from Discontinued Operations over the past three periods registered 5070000.0, 5072000.0, and 331000.0 for Q1 2024, Q4 2023, and Q4 2022 respectively.

Peer Comparison